Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

Measuring the quality of MDT working: an observational approach

Authors: Cath Taylor, Louise Atkins, Alison Richardson, Ruth Tarrant, Amanda-Jane Ramirez

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Cancer multidisciplinary teams (MDTs) are established in many countries but little is known about how well they function. A core activity is regular MDT meetings (MDMs) where treatment recommendations are agreed. A mixed methods descriptive study was conducted to develop and test quality criteria for observational assessment of MDM performance calibrated against consensus from over 2000 MDT members about the “characteristics of an effective MDT”.

Methods

Eighteen of the 86 ‘Characteristics of Effective MDTs’ were considered relevant and feasible to observe. They collated to 15 aspects of MDT working covering four domains: the team (e.g. attendance, chairing, teamworking); infrastructure for meetings (venue, equipment); meeting organisation and logistics; and patient-centred clinical decision-making (patient-centredness, clarity of recommendations). Criteria for rating each characteristic from ‘very poor’ to ‘very good’ were derived from literature review, observing MDMs and expert input. Criteria were applied to 10 bowel cancer MDTs to assess acceptability and measure variation between and within teams. Feasibility and inter-rater reliability was assessed by comparing three observers.

Results

Observational assessment was acceptable to teams and feasible to implement. Total scores from 29 to 50 (out of 58) highlighted wide diversity in quality between teams. Eight teams were rated either ‘very good/good’ or ‘very poor/poor’ for at least three domains demonstrating some internal consistency. ‘Very good’ ratings were most likely for attendance and administrative preparation, and least likely for patient-centredness of decision-making and prioritisation of complex cases. All except two characteristics had intra-class correlations of ≥0.50.

Conclusions

This observational tool (MDT-OARS) may contribute to the assessment of MDT performance. Further testing to confirm validity and reliability is required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Taylor C, Munro AJ, Glynne-Jones R, Griffiths C, Trevatt P, Richards MA, Ramirez AJ: Multidisciplinary team working in cancer: where are we now?. British Medical Journal BMJ. 2010, 340: c951-10.1136/bmj.c951.CrossRefPubMed Taylor C, Munro AJ, Glynne-Jones R, Griffiths C, Trevatt P, Richards MA, Ramirez AJ: Multidisciplinary team working in cancer: where are we now?. British Medical Journal BMJ. 2010, 340: c951-10.1136/bmj.c951.CrossRefPubMed
2.
go back to reference Lamb B, Brown K, Nagpal K, Vincent C, Green JSA, Sevdalis N: Team decision making by cancer care multidisciplinary teams: a systematic review. Ann Surg Oncol. 2011, 18 (8): 2116-2125. 10.1245/s10434-011-1675-6.CrossRefPubMed Lamb B, Brown K, Nagpal K, Vincent C, Green JSA, Sevdalis N: Team decision making by cancer care multidisciplinary teams: a systematic review. Ann Surg Oncol. 2011, 18 (8): 2116-2125. 10.1245/s10434-011-1675-6.CrossRefPubMed
3.
go back to reference Department of Health: The Manual for Cancer Services. 2004, Department of Health, London Department of Health: The Manual for Cancer Services. 2004, Department of Health, London
4.
go back to reference National Cancer Action Team: National Cancer Peer Review Programme 2004–2007. National Report: An Overview of the Findings from the Second National Round of Peer Reviews of Cancer Services in England. 2008, National Cancer Action Team, London National Cancer Action Team: National Cancer Peer Review Programme 2004–2007. National Report: An Overview of the Findings from the Second National Round of Peer Reviews of Cancer Services in England. 2008, National Cancer Action Team, London
5.
go back to reference Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, Phillips H, Gilmour H, Patel D, de Beaux A, Paterson-Brown S: The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus. 2006, 19 (6): 496-503. 10.1111/j.1442-2050.2006.00629.x.CrossRefPubMed Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, Phillips H, Gilmour H, Patel D, de Beaux A, Paterson-Brown S: The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus. 2006, 19 (6): 496-503. 10.1111/j.1442-2050.2006.00629.x.CrossRefPubMed
6.
go back to reference Coory M, Gkolia P, Yang I, Bowman R, Fong K: Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008, 60: 14-21. 10.1016/j.lungcan.2008.01.008.CrossRefPubMed Coory M, Gkolia P, Yang I, Bowman R, Fong K: Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008, 60: 14-21. 10.1016/j.lungcan.2008.01.008.CrossRefPubMed
7.
go back to reference Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D: MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer. 2006, 94 (3): 351-357. 10.1038/sj.bjc.6602947.CrossRefPubMedPubMedCentral Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D: MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer. 2006, 94 (3): 351-357. 10.1038/sj.bjc.6602947.CrossRefPubMedPubMedCentral
8.
go back to reference Leo F, Venissac N, Poudenx M, Otto J: Mourox Jand the Groupe d'Oncologie Thoracique Azureen (GOThA): Multidisciplinary management of lung cancer: how to test its efficacy?. J Thorac Oncol. 2007, 2 (1): 69-72. 10.1097/JTO.0b013e31802bff56.CrossRefPubMed Leo F, Venissac N, Poudenx M, Otto J: Mourox Jand the Groupe d'Oncologie Thoracique Azureen (GOThA): Multidisciplinary management of lung cancer: how to test its efficacy?. J Thorac Oncol. 2007, 2 (1): 69-72. 10.1097/JTO.0b013e31802bff56.CrossRefPubMed
9.
go back to reference Stalfors J, Lundberg C, Westin T: Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer. Acta Otolaryngol (Stockh). 2007, 127 (1): 82-87. 10.1080/00016480600740589.CrossRef Stalfors J, Lundberg C, Westin T: Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer. Acta Otolaryngol (Stockh). 2007, 127 (1): 82-87. 10.1080/00016480600740589.CrossRef
10.
go back to reference Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL: Analysis of clinical decision-making in multidisciplinary cancer teams. Ann Oncol. 2006, 17 (3): 457-460. 10.1093/annonc/mdj102.CrossRefPubMed Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL: Analysis of clinical decision-making in multidisciplinary cancer teams. Ann Oncol. 2006, 17 (3): 457-460. 10.1093/annonc/mdj102.CrossRefPubMed
11.
go back to reference Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS: Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011, 35 (9): 1970-1976. 10.1007/s00268-011-1152-1.CrossRefPubMed Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS: Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011, 35 (9): 1970-1976. 10.1007/s00268-011-1152-1.CrossRefPubMed
12.
go back to reference Lanceley AS, Savage J, Menon U, Jacobs I: Influences on multidisciplinary team decision-making. Int J Gynecol Cancer. 2008, 18 (2): 215-222. 10.1111/j.1525-1438.2007.00991.x.CrossRefPubMed Lanceley AS, Savage J, Menon U, Jacobs I: Influences on multidisciplinary team decision-making. Int J Gynecol Cancer. 2008, 18 (2): 215-222. 10.1111/j.1525-1438.2007.00991.x.CrossRefPubMed
13.
go back to reference Kidger J, Murdoch J, Donovan JL, Blazeby JM: Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009, 116 (4): 511-517. 10.1111/j.1471-0528.2008.02066.x.CrossRefPubMed Kidger J, Murdoch J, Donovan JL, Blazeby JM: Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009, 116 (4): 511-517. 10.1111/j.1471-0528.2008.02066.x.CrossRefPubMed
14.
go back to reference Carthey: The role of structured observational research in healthcare. Qual Saf Health Care. 2003, 12 (Suppl II): ii13-ii16.PubMedPubMedCentral Carthey: The role of structured observational research in healthcare. Qual Saf Health Care. 2003, 12 (Suppl II): ii13-ii16.PubMedPubMedCentral
15.
go back to reference Bower P, Campbell S, Bojke C, Sibbald B: Team structure, team climate and the quality of care in primary care: an observational study. Qual Saf Health Care. 2003, 12: 273-279. 10.1136/qhc.12.4.273.CrossRefPubMedPubMedCentral Bower P, Campbell S, Bojke C, Sibbald B: Team structure, team climate and the quality of care in primary care: an observational study. Qual Saf Health Care. 2003, 12: 273-279. 10.1136/qhc.12.4.273.CrossRefPubMedPubMedCentral
16.
go back to reference Undre S, Sevdalis N, Vincent C: Observing and assessing surgical teams: The Observational Teamwork Assessment for Surgery©(OTAS)©. Safer surgery: analysing behaviour in the operating theatre. Ashgate. Edited by: Flin R, Mitchell L. 2009 Undre S, Sevdalis N, Vincent C: Observing and assessing surgical teams: The Observational Teamwork Assessment for Surgery©(OTAS)©. Safer surgery: analysing behaviour in the operating theatre. Ashgate. Edited by: Flin R, Mitchell L. 2009
17.
18.
go back to reference Taylor C, Ramirez AJ: Multidisciplinary team members' views about MDT working: results from a survey commissioned by the National Cancer Action Team. 2009, National Cancer Action Team, , Available at: www.ncin.org.uk/mdt Taylor C, Ramirez AJ: Multidisciplinary team members' views about MDT working: results from a survey commissioned by the National Cancer Action Team. 2009, National Cancer Action Team, , Available at: www.ncin.org.uk/mdt
20.
go back to reference Taylor C, Sippitt J, Collins G, McManus C, Richardson A, Dawson J, Richards M, Ramirez A: A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC Health Serv Res. 2010, 10: 187-10.1186/1472-6963-10-187.CrossRefPubMedPubMedCentral Taylor C, Sippitt J, Collins G, McManus C, Richardson A, Dawson J, Richards M, Ramirez A: A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC Health Serv Res. 2010, 10: 187-10.1186/1472-6963-10-187.CrossRefPubMedPubMedCentral
22.
go back to reference National Institute for Clinical Excellence: Guidance on cancer services: improving supportive and palliative care for adults with cancer. 2004, NICE, London National Institute for Clinical Excellence: Guidance on cancer services: improving supportive and palliative care for adults with cancer. 2004, NICE, London
23.
go back to reference Lamb BW, Wong HWL, Vincent C, Green JSA, Sevdalis N: Teamwork and team performance in multidisciplinary cancer teams: development and evaluation of an observational tool. BMJ Qual Saf. 2011, 20 (10): 849-856. 10.1136/bmjqs.2010.048660.CrossRefPubMed Lamb BW, Wong HWL, Vincent C, Green JSA, Sevdalis N: Teamwork and team performance in multidisciplinary cancer teams: development and evaluation of an observational tool. BMJ Qual Saf. 2011, 20 (10): 849-856. 10.1136/bmjqs.2010.048660.CrossRefPubMed
Metadata
Title
Measuring the quality of MDT working: an observational approach
Authors
Cath Taylor
Louise Atkins
Alison Richardson
Ruth Tarrant
Amanda-Jane Ramirez
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-202

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine